Alkem Laboratories Limited
LIC reduced its stake in Alkem Laboratories from 1.43% to 1.34%, selling 1,09,310 shares.
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.